RECURRENT SUPRATENTORIAL GLIOBLASTOMA
Clinical trials for RECURRENT SUPRATENTORIAL GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SUPRATENTORIAL GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT SUPRATENTORIAL GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetically modified immune cells take on deadly brain tumors
Disease control Recruiting nowThis early-stage trial tests genetically engineered natural killer (NK) cells in 25 people with recurrent glioblastoma, an aggressive brain cancer. The cells are designed to resist the tumor's defenses. The main goal is to find a safe dose and check for side effects, while also w…
Matched conditions: RECURRENT SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Brain tumor virus therapy takes on chemo in Head-to-Head trial
Disease control Recruiting nowThis trial compares a virus-based treatment called lerapolturev to the chemotherapy drug lomustine in adults with recurrent glioblastoma, an aggressive brain cancer. Lerapolturev is injected directly into the tumor and later under the skin around the neck lymph nodes to stimulate…
Matched conditions: RECURRENT SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC